India  

Johnson & Johnson COVID-19 vaccine rollout on pause in US over blood clot concerns

Proactive Investors Tuesday, 13 April 2021
Johnson & Johnson (NYSE:JNJ) got its COVID-19 vaccine suspended in the US after six cases of blood clots were reported. The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) said this decision was taken “out of an abundance of caution” while investigations are ongoing. READ: Johnson & Johnson receives US approval for COVID-19 vaccine, to test it on babies “This is important, in part, to ensure that the health care provider community is aware of the potential for these adverse events and can plan for proper recognition and management due to the unique treatment required with this type of blood clot,” a statement read. “Right now, these adverse events appear to be extremely rare. COVID-19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously.” As of April 12, 6.8mln people had received the single-dose jab with six people experiencing a rare and severe type of blood clot. These were all women between the ages of 18 and 48 and symptoms occurred 6 to 13 days after vaccination. Treatment of this specific type of blood clot is different from the treatment that might typically be administered, the US authorities said. Usually, an anticoagulant drug called heparin is used to treat blood clots but administration of heparin may be dangerous in this setting, so the patients had to receive alternative treatment. The CDC and FDA added that people who have received the J&J vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider. Shares shed 3% to US$156.82 just before open.
0
shares
ShareTweetSavePostSend
 
Video Credit: CBS 3 Philly - Published
News video: Dr. Thomas Farley Joins CBS3 To Discuss Pause Of Johnson & Johnson Vaccine

Dr. Thomas Farley Joins CBS3 To Discuss Pause Of Johnson & Johnson Vaccine 03:35

The use of the Johnson & Johnson COVID-19 vaccine is on pause over blood clot concerns in a handful of women.

You Might Like


Related videos from verified sources

India has 37,36,648 active COVID-19 cases till date [Video]

India has 37,36,648 active COVID-19 cases till date

India reported 4,03,738 new COVID-19 cases in the last 24 hours. With 37,36,648 total active cases, COVID caseload of the country stood at 2,22,96,414. 4,092 new deaths took the death toll to 2,42,362..

Credit: ANI     Duration: 01:59Published
Pop-Up Vaccination Sites Across NYC Offering COVID Shots To Any U.S. Resident Over Age 18 [Video]

Pop-Up Vaccination Sites Across NYC Offering COVID Shots To Any U.S. Resident Over Age 18

New York City is now offering vaccines for some tourists.

Credit: CBS 2 New York     Duration: 00:39Published
Report: NY Attorney General Investigating Calls By Cuomo Aide Larry Schwartz [Video]

Report: NY Attorney General Investigating Calls By Cuomo Aide Larry Schwartz

The sexual harassment investigation into Gov. Andrew Cuomo is now reportedly expanding to include whether the vaccine rollout was politicized.

Credit: CBS 2 New York     Duration: 00:32Published